ATLASCo-Diagnostics (CODX) earnings date: Nov 12, 2026
Co-Diagnostics (CODX) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 12, 2026 (confirmed), after the close. Analysts expect EPS of -$1.25. Free email alerts for this report are just below.
Source: company filings and exchange data · Updated Nov 3, 2026
ATLAS view on CODX
| Last price | $0.38 (+7.5%) |
|---|---|
| Normal 1-day range (±1σ) | ±7.6% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Co-Diagnostics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Get an email before and after Co-Diagnostics reports, free with your ATLAS account
Earnings alerts are a free benefit of your ATLAS account. The company goes to your watchlist and we email you when it reports. Google signup is one click.
Create free accountCODX earnings at a glance
| Next report (confirmed) | Thu, Nov 12, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$1.25 |
| Last report | Aug 13, 2026 · Beat |
| Beat rate (last 5 reports) | 2 of 5 (40%) |
| Average EPS surprise | +4.2% |
| Average move around a report | ±7.1% (last 5) |
| Sector | Healthcare · Medical Devices |
Co-Diagnostics earnings history: last 5 reports
Co-Diagnostics last reported on Aug 13, 2026: EPS of -$1.45 against an estimate of -$3.00 (+51.7% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 13, 2026 | -$3.00 | -$1.45 | +51.7% | Beat | -5.4% |
| Jul 16, 2026 | $1.10 | $1.17 | +6.4% | Beat | -1.2% |
| May 14, 2026 | -$3.75 | -$4.09 | -9.1% | Miss | -19.7% |
| Mar 31, 2026 | -$3.60 | -$4.44 | -23.3% | Miss | -4.7% |
| Feb 23, 2026 | $0.42 | $0.40 | -4.8% | Miss | -4.7% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for CODX
See the fair value, the probability range and the earnings history of Co-Diagnostics on its ATLAS page.
Co-Diagnostics (CODX) stock analysisPlans from €3.99 a month.
Co-Diagnostics earnings: frequently asked questions
When does Co-Diagnostics (CODX) report earnings?
Co-Diagnostics is scheduled to report on Thursday, November 12, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for CODX?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$1.25 per share (USD). Estimates can change before the report.
How often does CODX beat earnings estimates?
Of its last 5 reports with a recorded result, Co-Diagnostics beat the EPS estimate 2 times; the average surprise was +4.2%. Past results do not predict the next one.
How much does CODX move around earnings?
Over its last 5 reports the stock moved an average of 7.1% (absolute, from the close before the report day to the close after it), and finished higher 0 of 5 times.
Did Co-Diagnostics beat earnings estimates last quarter?
Co-Diagnostics last reported on Aug 13, 2026: EPS of -$1.45 against an estimate of -$3.00 (+51.7% surprise), a beat.
How much does CODX usually move in a day?
On a normal trading day the ATLAS model puts CODX’s one-day range at about ±7.6%, with a 48% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 12, 2026
Educational information, not investment advice. Disclaimer